the aid library

LIST OPTIONS

Filter

12216

Children and armed conflict - Report of the Secretary-General (A/73/907–S/2019/509)

UN Security Council, UN General Assembly (2019) C1

The present report, which covers the period from January to December 2018, is submitted pursuant to Security Council resolution 2427 (2018). The preparation of the report involved broad consultations within the United Nations, in the field and at Headquarters, and with relevant Member States. It hig... more

Download (108)

View PDF (130)

Expanding our understanding of post COVID-19 condition: report of a WHO webinar

World Health Organization WHO (2021) C_WHO

On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC... more

Download (161)

View PDF (294)

COVAX: Structure and Principles

World Health Organization WHO (2022) C_WHO

This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of... more

Download (184)

View PDF (256)

Gesundheit braucht Politik. Sonderausgabe Soziale Determinanten von Gesundheit

Verein demokratischer Ärztinnen und Ärzte (2015) C1

Accessed 4 March 2019.

Download (1101)

View PDF (1513)

Core Set of Indicators & Indicator Data Sheets for Health and Social Health Protection

Deutsche Gesellschaft fü; r Internationale Zusammenarbeit (GIZ) GmbH ; KfW (2012)

The Core Set of Indicators and respective Indicator Data Sheets aim to pave the way towards a common understanding, greater consistency and comparability across countries and alignment of results chains of German Development Cooperation in the field of health and social health protection with the in... more

Download (701)

View PDF (1006)

Sexual and Reproductive Health of Women and Adolescent Girls Living With HIV

EngenderHealt; UNFPA (2008)

guidance for health managers, health workers, and activists

External Link

Germanys expanding role in global health

Ilona Kickbusch, Christian Franz, Anna Holzscheiter, Iris Hunger, Albrecht Jahn, Carsten Kö; hler, Oliver Razum, Jean-Olivier Schmidt Lancet 2017; 390: 898– 912 (2017) CC

Germany has become a visible actor in global health in the past 10 years. In this Series paper, we describe how this development complements a broad change in perspective in German foreign policy.

Download (180)

View PDF (205)

Central Medical Stores Botswana 2010 – 2012 Strategic Plan

Thomson, D., Shivanandan, J. &; Brown, T. Ministry of Health, Botswana; PEPFAR; SCMS (2010)

Measurement properties and interpretation of three shortened versions of the asthma control questionnaire

Juniper, E. F.; Svensson, K.; Mörk, A-C.; et al. Respiratory Medicine (2005) 99, 553–558 (2005) CC2

The Asthma Control Questionnaire (ACQ)1 was developed and validated to measure the primary clinical goal of asthma management as identified by international guidelines. They indicate that to achieve good control, treatment should minimise day and night time symptoms, activity limitation, airway narr... more

Download (216)

View PDF (354)

The Union's desk Guide für diagnosis and management of TB in children (Asia-Edition)

Stephen M. Graham USAID, l'Union, Initiative 5%; et. al (2016)

Third edition 2016

Download (193)

View PDF (172)

Etude Des Interactions Entre Les Differents Acteurs Des Interventions Sous Directives Communautaires Et Changements Obtenus Au Benin Et Au Togo

Malou Adom P. V.1, Makoutode Ch. P.2, Gnaro T.3, Ouro-Koura A.-R.4, Ouendo E. M.5, Napo-Koura G.6, Makoutode M.7 J. Rech. Sci. Univ. Lomé (Togo), Centre de Formation en Santé Publique (2016) C2

Introduction : Pour la mise en oeuvre des interventions sous directives communautaires, les Etats ont retenu le profil des agents de santé communautaire de même et le rôle et responsabilité que chaque acteur doit jouer. L’objectif du présent travail est d’étudier les interactions entre ... more

No Protection, No Respect

Safeguarding Health in Conflict Coalition (2016) CC

Health Workers and Health Facilities under Attack 2015, and Early 2016

Download (290)

View PDF (385)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

External Link

Achieving universal electrification of rural healthcare facilities in sub-Saharan Africa with decentralized renewable energy technologies

Moner-Girona, M.; et al. (2021) CC

Joule 5, 2687–2714 October 20, 2021 Cell Press

HIV Testing and Counselling (HTC) Plan, Malawi

Government of Malawi, Ministry of Health (2015) C1

The 5 years plan to scale up HIV Testing and Counselling Services in Malawi 2006-2010

External Link

Trauma and Emergency Surgery Kit (TESK) 2019

World Health Organization WHO (2019) C_WHO

For 50 patients requiring surgical care in emergency situations assuming 2 operations per patient (100 interventions) WHO trauma and emergency surgery kit (TESK) aims to provide materials and drugs to meet the needs of ...0 patients requiring surgical care in emergency situations, assuming an average of two operations per patient. This kit is intended for use by health care providers who are trained in appropriate management of emergent surgical issues and are acting within their scope of practise. It is designed for use in areas where basic levels of infrastructure exist. The composition of TESK has recently been revised in collaboration with the International Committee of the Red Cross to meet the dynamic requirements of emergency situations. In general, this kit contains oral and IV medicines including cold chain drugs and medical supplies including renewables and instruments. WHO TESK is intended to provide the resources needed for surgical procedures in operating theatres. Some of the sub-units may be used for simpler procedures that may occur in other parts of the facility. more

Download (587)

View PDF (463)

Remarkable progress, new horizons and renewed commitment: Ending preventable maternal, newborn and child deaths in South-East Asia Region

World Health Organization (WHO), Regional Office for South-East-Asia (2016) C_WHO

At the threshold of Sustainable Development Goals (SDG) era, this document captures the remarkable achievements by Member States towards achieving MDGs 4 and 5. It acknowledges new opportunities in the post-2015 phase shaped by the SDGs and the Glo... more

Download (107)

View PDF (141)

Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020
recommended

World Health Organization WHO (2020) CC

The results of a WHO survey conducted to assess the impact of the COVID-19 pandemic on up to 25 essential health services in countries show disruptions of essential health services in nearly all countries, and more so in lower-income than higher-income countries. The great majority of service disrup... more

A situational analysis of programmatic management of TB preventive treatment in the WHO South-East Asia Region

World Health Organization WHO (2020) C_WHO

Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition... more

Download (171)

View PDF (241)

Strategy to respond to antimalarial drug resistance in Africa

World Health Organization WHO (2022) C_WHO

The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i... more

Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020 recommended

Pulse survey on continuity of essential health services during the COVID-19 pandemic: interim report, 27 August 2020
recommended